Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FCMYP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,183
Award facts
- Contract value 100% obligated
- $11,182.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Photrexa Cross-Linking Kit 6ml. This delivery order, issued on August 22, 2025, carries a firm fixed price and an ultimate completion date of September 15, 2025. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market while leveraging its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of contract awards covering branded and generic prescription drugs, biologics, medical consumables, and specialty medications to military and federal healthcare systems. The Photrexa Cross-Linking Kit delivery supports this mission by providing ophthalmic pharmaceutical products essential to DoD medical operations.
Quick answers
Who was awarded contract SPE2DB25FCMYP?
SPE2DB25FCMYP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FCMYP worth?
The government has obligated $11,183 on SPE2DB25FCMYP.
Is contract SPE2DB25FCMYP an order under another contract?
Yes. SPE2DB25FCMYP is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMYP competed?
The extent of competition for SPE2DB25FCMYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award